Ulrik Dalgas1, Martin Langeskov-Christensen2, Egon Stenager3,4,5, Morten Riemenschneider2, Lars G Hvid2. 1. Department of Public Health, Section for Sport Science, Aarhus University, Aarhus, Denmark. dalgas@ph.au.dk. 2. Department of Public Health, Section for Sport Science, Aarhus University, Aarhus, Denmark. 3. Department of Neurology, Hospital of Southern Jutland, Sønderborg, Denmark. 4. Department of Regional Health Research, University of Southern Denmark, Odense, Denmark. 5. MS Clinics of Southern Jutland (Sønderborg, Esbjerg, Kolding), Hospital of Southern Jutland, Sønderborg, Denmark.
Abstract
PURPOSE OF REVIEW: For many years, exercise was controversial in multiple sclerosis (MS) and thought to exacerbate symptoms and fatigue. However, having been found to be safe and effective, exercise has become a cornerstone of MS rehabilitation and may have even more fundamental benefits in MS, with the potential to change clinical practice again. The aim of this review is to summarize the existing knowledge of the effects of exercise as primary, secondary, and tertiary prevention in MS. RECENT FINDINGS: Initial studies established exercise as an effective symptomatic treatment (i.e., tertiary prevention), but recent studies have evaluated the disease-modifying effects (i.e., secondary prevention) of exercise as well as the impact on the risk of developing MS (i.e., primary prevention). Based on recent evidence, a new paradigm shift is proposed, in which exercise at an early stage should be individually prescribed and tailored as "medicine" to persons with MS, alongside conventional medical treatment.
PURPOSE OF REVIEW: For many years, exercise was controversial in multiple sclerosis (MS) and thought to exacerbate symptoms and fatigue. However, having been found to be safe and effective, exercise has become a cornerstone of MS rehabilitation and may have even more fundamental benefits in MS, with the potential to change clinical practice again. The aim of this review is to summarize the existing knowledge of the effects of exercise as primary, secondary, and tertiary prevention in MS. RECENT FINDINGS: Initial studies established exercise as an effective symptomatic treatment (i.e., tertiary prevention), but recent studies have evaluated the disease-modifying effects (i.e., secondary prevention) of exercise as well as the impact on the risk of developing MS (i.e., primary prevention). Based on recent evidence, a new paradigm shift is proposed, in which exercise at an early stage should be individually prescribed and tailored as "medicine" to persons with MS, alongside conventional medical treatment.
Authors: Gavin Giovannoni; Helmut Butzkueven; Suhayl Dhib-Jalbut; Jeremy Hobart; Gisela Kobelt; George Pepper; Maria Pia Sormani; Christoph Thalheim; Anthony Traboulsee; Timothy Vollmer Journal: Mult Scler Relat Disord Date: 2016-07-07 Impact factor: 4.339
Authors: Jeffrey A Cohen; Arun V Krishnan; Andrew D Goodman; James Potts; Ping Wang; Eva Havrdova; Chris Polman; Richard A Rudick Journal: JAMA Neurol Date: 2014-11 Impact factor: 18.302
Authors: Brian Mark Lozinski; Luiz Gustavo Nogueira de Almeida; Claudia Silva; Yifei Dong; Dennis Brown; Sameeksha Chopra; V Wee Yong; Antoine Dufour Journal: Sci Rep Date: 2021-03-31 Impact factor: 4.379
Authors: Peter Flachenecker; Anna Karoline Bures; Angeli Gawlik; Ann-Christin Weiland; Sarah Kuld; Klaus Gusowski; René Streber; Klaus Pfeifer; Alexander Tallner Journal: Int J Environ Res Public Health Date: 2020-06-24 Impact factor: 3.390
Authors: Rosalind Kalb; Theodore R Brown; Susan Coote; Kathleen Costello; Ulrik Dalgas; Eric Garmon; Barbara Giesser; June Halper; Herb Karpatkin; Jennifer Keller; Alexander V Ng; Lara A Pilutti; Amanda Rohrig; Paul Van Asch; Kathleen Zackowski; Robert W Motl Journal: Mult Scler Date: 2020-04-23 Impact factor: 6.312
Authors: Morten Riemenschneider; Lars G Hvid; Steffen Ringgaard; Mikkel K E Nygaard; Simon F Eskildsen; Thor Petersen; Egon Stenager; Ulrik Dalgas Journal: BMJ Open Date: 2021-01-12 Impact factor: 2.692
Authors: Julia Schüler; Wanja Wolff; Julian Pfeifer; Romina Rihm; Jessica Reichel; Gerhard Rothacher; Christian Dettmers Journal: Front Psychol Date: 2021-01-28
Authors: Nadine Patt; Jan Kool; Ruth Hersche; Max Oberste; David Walzik; Niklas Joisten; Daniel Caminada; Francesca Ferrara; Roman Gonzenbach; Claudio Renato Nigg; Christian Philipp Kamm; Philipp Zimmer; Jens Bansi Journal: BMC Neurol Date: 2021-02-11 Impact factor: 2.474